Neith Corporation (TPEX:6236)
Taiwan · Delayed Price · Currency is TWD 16.90
0.00 (0.00%)
Oct 2, 2026, 12:36 PM CST
Neith Market Cap
Neith has a market cap or net worth of 703.95 million as of October 9, 2026. It is the 36,429th most valuable company in the world and the 2,182nd biggest in Taiwan. Its market cap has decreased by 44.95% in one year.
Market Cap
703.95M
Enterprise Value
570.49M
Revenue
31.84M
Global Rank
Country Rank
#2,182 Taiwan
PE Ratio
2,172.70
ChartMarket Cap Chart
Since November 3, 2004, Neith's market cap has increased from 483.77M to 703.95M, an increase of 45.51%. That is a compound annual growth rate of 1.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 703.95M | -21.58% |
| Dec 30, 2025 | 897.64M | -27.93% |
| Dec 27, 2024 | 1.25B | -13.21% |
| Dec 29, 2023 | 1.43B | 166.67% |
| Dec 30, 2022 | 538.12M | 47.83% |
| Dec 30, 2021 | 364.02M | 7.98% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MegaPro Biomedical | 883.44M |
| NatureWise Biotech & Medicals | 809.22M |
| TCI GENE | 787.53M |
| BioLASCO Taiwan | 729.94M |
| Taiwan Advance Bio-Pharmaceutical | 670.50M |
| Enimmune | 660.00M |
| SynCore Biotechnology Co.,Ltd | 629.45M |
| Lukas Biomedical | 585.16M |